Fulgent Genetics, Inc. (FLGT): Price and Financial Metrics

Fulgent Genetics, Inc. (FLGT)

Today's Latest Price: $36.14 USD

6.45 (21.72%)

Updated Aug 5 8:00pm

Add FLGT to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 58 in Medical - Diagnostics/Research

See all "A" rated Strong Buy stocks

FLGT Stock Summary

  • With a one year PEG ratio of 1,520.79, Fulgent Genetics Inc is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than 97.25% of US stocks.
  • Price to trailing twelve month operating cash flow for FLGT is currently 110.54, higher than 97.15% of US stocks with positive operating cash flow.
  • With a price/sales ratio of 18.45, Fulgent Genetics Inc has a higher such ratio than 91.88% of stocks in our set.
  • Stocks that are quantitatively similar to FLGT, based on their financial statements, market capitalization, and price volatility, are EPAY, WIX, PSTG, DMRC, and FEYE.
  • Visit FLGT's SEC page to see the company's official filings. To visit the company's web site, go to www.fulgentgenetics.com.
FLGT Daily Price Range
FLGT 52-Week Price Range

FLGT Stock Price Chart Technical Analysis Charts

FLGT Price/Volume Stats

Current price $36.14 52-week high $43.64
Prev. close $29.69 52-week low $6.70
Day low $34.36 Volume 1,796,955
Day high $43.64 Avg. volume 415,040
50-day MA $19.29 Dividend yield N/A
200-day MA $14.90 Market Cap 788.21M

Fulgent Genetics, Inc. (FLGT) Company Bio

Fulgent Genetics, Inc., a technology company, focuses on providing genetic testing services to physicians with clinically actionable diagnostic information. It intends to provide tests to hospitals and medical institutions. The company was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016. The company was founded in 2011 and is based in Temple City, California.

FLGT Latest News Stream

Event/Time News Detail
Loading, please wait...

FLGT Latest Social Stream

Loading social stream, please wait...

View Full FLGT Social Stream

Latest FLGT News From Around the Web

Below are the latest news stories about Fulgent Genetics Inc that investors may wish to consider to help them evaluate FLGT as an investment opportunity.

Old West Investment Management Q2 2020 Investor Letter

Original post Editor's Note: The summary bullets for this article were chosen by Seeking Alpha editors....

Fund Letters on Seeking Alpha | July 24, 2020

Focusing On Fulgent Genetics

Today's headlines need not be tomorrow's storyline." - Craig D. Lounsbrough Today, we look at a name that fell back into 'Busted IPO' territory at the end of COVID-19 meltdown. The shares have popped back sharply since then, like so many equities over the past several months. Should investors be...

Busted IPO Forum on Seeking Alpha | July 14, 2020

The Daily Biotech Pulse: Blueprint, Roche Ink $1.7B Cancer Drug Collaboration, INmune's Positive Alzheimer's Readout, Edwards, Abbott Settle Patent Lawsuits

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 13) Altimmune Inc (NASDAQ: ALT ) (announced positive preclinical data for its intranasal vaccine candidate AdCOVID) argenx SE – ADR (NASDAQ: ARGX ) Axonics Modulation Technologies Inc (NASDAQ: AXNX ) (reacted to preliminary second-quarter results) Beigene Ltd (NASDAQ: BGNE ) - announced $421 million in additional investment by Amgen, Inc. (NASDAQ: AMGN ) in a $2.1-billion direct offering by the Chinese biotech BioMarin Pharmaceutical Inc. (NASDAQ: BMRN ) Biondvax Pharmaceuticals Ltd – ADR (NASDAQ: BVXV ) Brainstorm Cell Therapeutics Inc (NASDAQ: BCLI ) Catalent Inc (NYSE: CTLT ) DexCom, Inc. (NASDAQ: DXCM ) Equillium Inc (NASDAQ: EQ (announced po...

Benzinga | July 14, 2020

Fulgent Genetics to Announce Second Quarter 2020 Financial Results on Tuesday August 4, 2020

TEMPLE CITY, Calif., July 14, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”) today announced that…

GlobeNewswire | July 14, 2020

Hedge Funds Aren’t Crazy About Fulgent Genetics, Inc. (FLGT) Anymore

We at Insider Monkey have gone over 821 13F filings that hedge funds and prominent investors are required to file by the SEC The 13F filings show the funds' and investors' portfolio positions as of March 31st, near the height of the coronavirus market crash. In this article, we look at what those funds think […]

Yahoo | June 25, 2020

Read More 'FLGT' Stories Here

FLGT Price Returns

1-mo 97.16%
3-mo 130.48%
6-mo 120.37%
1-year 252.24%
3-year 465.57%
5-year N/A
YTD 180.16%
2019 306.94%
2018 -27.63%
2017 -62.14%
2016 N/A
2015 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 1.0142 seconds.